123I-MIBG myocardial scintigraphy in patients with "takotsubo" cardiomyopathy

Journal of Nuclear Medicine

Volumn 45, Issue 7, 2004, Pages 1121-1127

  Akashi, Yoshihiro J ^a,b   Nakazawa, Kiyoshi ^b   Sakakibara, Masayoshi ^b   Miyake, Fumihiko ^b   Musha, Haruki ^b   Sasaka, Kaoru ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY   (Japan)

Author keywords

"Takotsubo" cardiomyopathy; 123I metaiodobenzlguanidine; Catecholamine; Reversible ventricular dysfunction; Stunned myocardium

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 123; METAIODOBENZYLGUANIDINE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SCINTISCANNING; HEART VENTRICLE WALL; HUMAN; MALE; PRIORITY JOURNAL; SYMPATHETIC TONE; TAKOTSUBO CARDIOMYOPATHY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; HEART LEFT VENTRICLE FUNCTION; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STUNNED HEART MUSCLE; SYNDROME; VALIDATION STUDY;

3-IODOBENZYLGUANIDINE; AGED; CARDIOMYOPATHIES; FEMALE; HUMANS; MALE; MYOCARDIAL STUNNING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYNDROME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 4043071344     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
2. Scott IU, Guttermann DD. Pheochromocytoma with reversible focal cardiac dysfunction. Am Heart J. 1995;130:909-911.
3. Brandspiegel HZ, Marinchak RA, Kowey PR. A broken heart. Circulation. 1998;98:1349.
4. Lee C, Wolfe KB, Rabson JL. Reversible biventricular dysfunction secondary to ischemia in a patient with acute airway obstruction: a case report and review of the literature on reversible causes of acute ventricular dysfunction. Can J Cardiol. 1999;15:705-708.
5. Owa M, Aizawa K, Urasawa N, et al. Emotional stress-induced 'ampulla cardiomyopathy': discrepancy between the metabolic and sympathetic innervation imaging performed during the recovery course. Jpn Circ J. 2001;65:349-352.
6. Tsuchihashi K, Ueshima K, Uchida T, et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. J Am Coll Cardiol. 2001;38:11-18.
7. 99mTc-tetrofosmin myocardial single photon emission computed tomography. Ann Nucl Med. 2001;15:351-355.
8. Moriya M, Mori H, Suzuki N, et al. Six-month follow-up of takotsubo cardiomyopathy with I-123-β-metyl-iodophenyl pentadecanoic acid and I-123-metaiodobenzyl-guanidine myocardial scintigraphy. Intern Med. 2002;41:829-833.
9. Kurisu S, Sato H, Kawagoe T, et al. Takotsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J. 2002;143:448-455.
10. Ueyama T, Kasamatsu K, Hano T, et al. Emotional stress induces transient left ventricular hypocontraction in the rat via activation of cardiac adrenoceptors: a possible animal model of 'takotsubo' cardiomyopathy. Circ J. 2002;66:712-713.
11. Akashi YJ, Sakakibara M, Miyake F. Reversible left ventricular dysfunction: "takotsubo" cardiomyopathy associated with pneumothorax. Heart. 2002;87:E1.
12. Akashi YJ, Nakazawa K, Sakakibara M, et al. Reversible left ventricular dysfunction: "takotsubo" cardiomyopathy related to catecholamine cardiotoxicity. J Electrocardiol. 2002;35:351-356.
13. Abe Y, Kondo M, Matsuoka R, et al. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol. 2003;41:737-742.
14. Kurisu S, Inoue I, Kawagoe T, et al. Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction. J Am Coll Cardiol. 2003;41:743-748.
15. Akashi YJ, Nakazawa K, Kida K, et al. Reversible ventricular dysfunction (takotsubo cardiomyopathy) following polymorphic ventricular tachycardia. Can J Cardiol. 2003;19:449-451.
16. Akashi YJ, Nakazawa K, Sakakibara M, et al. The clinical features of takotsubo cardiomyopathy. QJM. 2003;96:563-573.
17. Valette H, Syrota A. Nuclear techniques in the assessment of myocardial innervation. In: Murry IPC, EII PJ, eds. Nuclear Medicine in Clinical Diagnosis and Treatment. Edinburgh, U.K.: Churchill Livingstone; 1998:1525-1529.
18. 131I] meta-iodobenzylguanidine. J Nucl Med. 1981;22:358-364.
19. Tobes MC, Jaques S Jr, Wieland DM, et al. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med. 1985;26:897-907.
20. Schofer J, Spielmann R, Schuchert A, et al. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1988;12:1252-1258.
21. Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471-477.
22. Delahaye N, Dinanian S, Slama MS, et al. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med. 1999;26:416-424.
23. Choi JY, Lee KH, Hong KP, et al. Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity. J Nucl Cardiol. 2001;8:4-9.
24. Shimizu M, Ino H, Yamaguchi M, et al. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy. J Nucl Med. 2002;43:15-20.
25. Chapman CB, Baker O, Raynolds J, Bonte FJ. Use of biplane cineangiography for measurement of ventricular volume. Circulation. 1958;18:1105-1117.
26. 123I-MIBG in normal human hearts [in Japanese]. Kaku Igaku. 1993;30:1359-1367.
27. 123I-metaiodobenzyl guanidine in Parkinson's disease. Nucl Med Commun. 1998;19:137-142.
28. Hattori N, Tamaki N, Hayashi T, et al. Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med. 1996;37:1985-1990.
29. Henderson EB, Kahn JK, Corbett JR, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation. 1988;78:1192-1199.
30. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship to autonomic neuropathy. Nucl Med Commun. 1996;17:621-632.
31. 201Tl uptake and cardiac autonomic function. Ann Nucl Med. 1998;12:323-331.
32. Kloner RA, Przyklenk K, Patel B. Altered myocardial states: the stunned and hibernating myocardium. Am J Med. 1989;86:14-22.
33. Pollick C, Cujec B, Parker S, et al. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: an echocardiographic study. J Am Coll Cardiol. 1988;12:600-605.